Picture of Accolade logo

ACCD Accolade News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Accolade Inc reports results for the quarter ended in January - Earnings Summary

* Accolade Inc  ACCD.OQ  reported a quarterly adjusted loss
of 35
cents​​ per share for the quarter ended in January, higher than
the same quarter last year, when the company reported EPS of -52
cents.  The mean expectation of sixteen analysts for the quarter
was for a loss of 48 cents per share. Wall Street expected
results to range from -56 cents to -44 cents per share.
    * Revenue rose 18.5% to $110.47 million from a year ago;
analysts
expected $105.22 million. 
    * Accolade Inc's reported EPS for the quarter was a loss
of 35
cents​.
    * The company reported a quarterly loss of $27.59 million.
    * Accolade Inc shares had fallen by 41.5% this quarter and
lost 49.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 26.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the healthcare
facilities & services peer group is also "buy"

Wall Street's median 12-month price target for Accolade Inc is
$13.00 
This summary was machine generated from LSEG data June 27 at
09:21 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 May. 31 2024      -0.48          -0.35          Beat
 Feb. 29 2024      -0.07          -0.10          Missed
 Nov. 30 2023      -0.44          -0.28          Beat
 Aug. 31 2023      -0.54          -0.43          Beat

Recent news on Accolade

See all news